Cargando…

Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice

In 2016, the NIH designated sexual and gender minorities (SGM) a health disparity population. The next year, the American Society of Clinical Oncology highlighted the need to improve the suboptimal cancer and survivorship care received by SGM populations. There are currently no evidence-based traini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosser, B. R. Simon, Rider, G. Nic, Kapoor, Aditya, Talley, Kristine M. C., Haggart, Ryan, Kohli, Nidhi, Konety, Badrinath R., Mitteldorf, Darryl, Polter, Elizabeth J., Ross, Michael W., West, William, Wheldon, Christopher, Wright, Morgan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Current and Future Topics on Prostate Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350223/ https://www.ncbi.nlm.nih.gov/pubmed/34430423 http://dx.doi.org/10.21037/tau-20-1052

Ejemplares similares

Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the Restore-2 Study
por: Rosser, B. R. Simon, et al.
Publicado: (2022)

Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment
por: Haggart, Ryan, et al.
Publicado: (2021)

Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors
por: Bates, Alex J., et al.
Publicado: (2022)

Prevalence and Risk Factors for Sexually Transmitted Infections in Gay and Bisexual Prostate Cancer Survivors: Results From the Restore-2 Study
por: Wheldon, Christopher W., et al.
Publicado: (2022)

Preface to “Current and Future Topics on Prostate Cancer”
por: Konety, Badrinath R., et al.
Publicado: (2021)

MRI/PET Imaging in elevated PSA and localized prostate cancer: a narrative review
por: Regmi, Subodh K., et al.
Publicado: (2021)

LOWER URINARY TRACT AND BOWEL SYMPTOMS PREDICT QUALITY OF LIFE IN GAY AND BISEXUAL PROSTATE CANCER SURVIVORS
por: Talley, Kristine M, et al.
Publicado: (2019)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

A role for pediatric oncologists/urologists?!
por: Stein, Raimund
Publicado: (2013)

Antiplatelet drugs and the perioperative period: What every urologist needs to know
por: Vasudeva, Pawan, et al.
Publicado: (2009)

Prostate ultrasound—for urologists only?: Tuesday 4 October 2005, 08:45–10:45
por: Frauscher, Ferdinand, et al.
Publicado: (2005)

The example of CaPSURE: lessons learned from a national disease registry
por: Porten, Sima P., et al.
Publicado: (2011)

BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
por: Lebacle, Cedric, et al.
Publicado: (2021)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

What every urologist should know about surgical trials Part I: Are the results valid?
por: Bajammal, Sohail, et al.
Publicado: (2008)

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
por: Lyou, Yung, et al.
Publicado: (2021)

Narrative review of management strategies and outcomes in node-positive prostate cancer
por: D’Rummo, Kevin A., et al.
Publicado: (2021)

Biomarkers for detection of clinically significant prostate cancer: contemporary clinical data and future directions
por: Eyrich, Nicholas W., et al.
Publicado: (2021)

Focal therapy for primary and salvage prostate cancer treatment: a narrative review
por: Tracey, Andrew T., et al.
Publicado: (2021)

Subtotal surgical therapy for localized prostate cancer: a single-center precision prostatectomy experience in 25 patients, and SEER-registry data analysis
por: Sood, Akshay, et al.
Publicado: (2021)

Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
por: Mahjoub, Samy, et al.
Publicado: (2021)

Epigenetics in prostate cancer: clinical implications
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer—a narrative review
por: Sagaram, Smitha, et al.
Publicado: (2021)

Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review
por: de Kouchkovsky, Ivan, et al.
Publicado: (2021)

Addressing Participant Validity in a Small Internet Health Survey (The Restore Study): Protocol and Recommendations for Survey Response Validation
por: Dewitt, James, et al.
Publicado: (2018)

Assessing kidney stone composition using smartphone microscopy and deep neural networks
por: Onal, Ege Gungor, et al.
Publicado: (2022)

Radiotherapy after Radical Prostatectomy: Treatment Recommendations Differ between Urologists and Radiation Oncologists
por: Lavallée, Luke T., et al.
Publicado: (2013)

The Influence of Companion Animals on Quality of Life of Gay and Bisexual Men Diagnosed with Prostate Cancer
por: Wright, Morgan M., et al.
Publicado: (2019)

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group
por: Diana, Pietro, et al.
Publicado: (2022)

“We talk it over” - mixed-method study of interdisciplinary collaborations in private practice among urologists and oncologists in Germany
por: Beermann, Sandra, et al.
Publicado: (2014)

What every urologist should know about surgical trials Part II: What are the results and should I apply them to patient care?
por: Bajammal, Sohail, et al.
Publicado: (2008)

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment
por: Da Rosa, M.R., et al.
Publicado: (2011)

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)
por: Murray, Louise J., et al.
Publicado: (2014)

Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study
por: Robertson, Nicola L., et al.
Publicado: (2014)

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
por: Ferraldeschi, Roberta, et al.
Publicado: (2015)

Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting
por: Donaldson, Ian A., et al.
Publicado: (2015)

Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy
por: Jensen, Lindsay, et al.
Publicado: (2017)

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
por: Nichols, R. Charles, et al.
Publicado: (2017)

Transurethral bipolar plasmakinetic vapo-enucleation of the prostate: Is it safe for patients on chronic oral anticoagulants and/or platelet aggregation inhibitors?
por: El-Shaer, Waleed, et al.
Publicado: (2017)

Day care bipolar transurethral resection vs photoselective vaporisation under sedoanalgesia: A prospective, randomised study of the management of benign prostatic hyperplasia
por: Sood, Rajeev, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eeklp9813vf9bmgq74tp279ssn